OLV Robotic Surgery Institute, Onze Lieve Vrouw (O.L.V.) Clinic Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
World J Urol. 2012 Oct;30(5):665-70. doi: 10.1007/s00345-012-0943-9. Epub 2012 Sep 11.
Limited data are available for the use of robot-assisted partial nephrectomy (RAPN) in tumors >4 cm. The objectives of this study were to report the perioperative outcomes of a series of patients who underwent RAPN for suspicious >4 cm renal tumors and to compare these results with those observed in a group of patients with ≤4 cm tumors.
We analyzed retrospectively the clinical records of 49 patients who underwent RAPN for suspicious of renal cell carcinoma (RCC) >4 cm in size at four centers from September 2008 to September 2010. All patients underwent da Vinci RAPN. The results were compared with those observed in a group of patients undergoing RAPN for ≤4 cm renal tumors.
The median warm ischemia time (WIT) was 22 min (Interquartile range [IQR] 18-28). The median console time was 145 min (median IQR 112-177). The median blood loss was 120 mL (IQR 62-237). In two cases, we observed intraoperative renal vein injury (4 %). Postoperative complications were reported in 13 (26.5 %) patients. Major complications were observed in 4 (8.2 %) cases. Patients with large tumors showed perioperative outcomes worse than those received the RAPN for ≤4 cm tumors. Conversely, no significant difference was observed in positive surgical margin (PSM) rates.
These outcomes support the use of RAPN as possible alternative to open PN for the treatment for patients with suspicious renal masses >4 cm. Positive surgical margin rates demonstrated RAPN is an oncologically safe procedure for tumors >4 cm.
机器人辅助部分肾切除术(RAPN)在>4cm 肿瘤中的应用数据有限。本研究的目的是报告一组接受 RAPN 治疗可疑>4cm 肾肿瘤患者的围手术期结果,并将这些结果与一组≤4cm 肿瘤患者的观察结果进行比较。
我们回顾性分析了 2008 年 9 月至 2010 年 9 月四个中心的 49 例接受 RAPN 治疗可疑肾细胞癌(RCC)>4cm 大小的患者的临床记录。所有患者均接受达芬奇 RAPN 治疗。结果与接受 RAPN 治疗≤4cm 肾肿瘤的患者进行比较。
中位热缺血时间(WIT)为 22min(IQR 18-28)。控制台中位时间为 145min(中位数 IQR 112-177)。中位出血量为 120ml(IQR 62-237)。术中观察到 2 例肾静脉损伤(4%)。13 例(26.5%)患者报告术后并发症。4 例(8.2%)患者出现严重并发症。大肿瘤患者的围手术期结果比接受 RAPN 治疗≤4cm 肿瘤的患者差。然而,阳性切缘(PSM)率无显著差异。
这些结果支持将 RAPN 作为开放性 PN 的替代方法,用于治疗可疑>4cm 肾肿瘤的患者。PSM 率表明 RAPN 对>4cm 肿瘤是一种具有肿瘤安全性的手术方法。